Mettler-Toledo International (NYSE:MTD) Coverage Initiated at Wolfe Research

Wolfe Research started coverage on shares of Mettler-Toledo International (NYSE:MTD - Free Report) in a research report report published on Friday morning. The firm issued a peer perform rating on the medical instruments supplier's stock.

Several other brokerages have also recently weighed in on MTD. Evercore ISI upped their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an "in-line" rating in a research report on Tuesday, October 1st. Robert W. Baird decreased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating on the stock in a report on Monday, November 11th. Wells Fargo & Company lowered their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating on the stock in a research note on Monday, November 11th. Stifel Nicolaus decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a report on Monday, November 11th. Finally, Citigroup raised Mettler-Toledo International from a "sell" rating to a "neutral" rating and lifted their price objective for the company from $1,200.00 to $1,300.00 in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $1,351.25.

Mettler-Toledo International Trading Up 0.0 %

Shares of MTD stock traded up $0.06 during trading on Friday, reaching $1,276.98. 118,953 shares of the company's stock traded hands, compared to its average volume of 135,506. The firm's 50-day moving average is $1,305.85 and its 200 day moving average is $1,377.40. The company has a market capitalization of $26.95 billion, a P/E ratio of 34.43, a PEG ratio of 4.19 and a beta of 1.13. Mettler-Toledo International has a 1 year low of $1,115.64 and a 1 year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. As a group, sell-side analysts predict that Mettler-Toledo International will post 40.42 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Elisha W. Finney sold 76 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now owns 240 shares of the company's stock, valued at approximately $314,820. This trade represents a 24.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the transaction, the insider now owns 6 shares in the company, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company's stock.

Institutional Investors Weigh In On Mettler-Toledo International

Institutional investors have recently bought and sold shares of the stock. Wealth Enhancement Advisory Services LLC grew its holdings in Mettler-Toledo International by 1.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 1,158 shares of the medical instruments supplier's stock worth $1,619,000 after acquiring an additional 14 shares during the last quarter. OFI Invest Asset Management bought a new stake in shares of Mettler-Toledo International in the second quarter worth about $802,000. Parsons Capital Management Inc. RI increased its holdings in Mettler-Toledo International by 7.2% during the 2nd quarter. Parsons Capital Management Inc. RI now owns 2,681 shares of the medical instruments supplier's stock valued at $3,747,000 after purchasing an additional 180 shares during the period. Carnegie Investment Counsel raised its position in Mettler-Toledo International by 0.8% during the 2nd quarter. Carnegie Investment Counsel now owns 13,963 shares of the medical instruments supplier's stock valued at $19,514,000 after purchasing an additional 109 shares during the last quarter. Finally, Walter Public Investments Inc. lifted its holdings in Mettler-Toledo International by 26.6% in the 2nd quarter. Walter Public Investments Inc. now owns 10,453 shares of the medical instruments supplier's stock worth $14,609,000 after buying an additional 2,194 shares during the period. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.